Table 4.

Differential miRNAs targeting genes in significant pathways in embryonic breast and hind muscles affected by L13 treatment.

Target	miRNA	p-value	FDR	Fold change (ΔC)	Regulation
Breast	let-7	0.0130	0.0658	1.85	Down
	miR-130c	0.00001	0.0012	1.54	Up
	miR-1677	0.0004	0.0048	2.01	Up
	miR-17-3p	0.0158	0.0761	1.56	Up
	miR-1908	0.0217	0.0962	1.86	Down
	miR-199b	0.0004	0.0044	1.87	Down
	miR-222	0.0017	0.0139	1.72	Up
	miR-312-5p	0.0480	0.1680	1.76	Up
	miR-460-5p	0.0267	0.1117	1.59	Down
	miR-4651	0.0198	0.0899	1.72	Down
	miR-4900a	0.0058	0.0361	2.30	Down
	miR-5109	0.0044	0.0292	1.51	Down
	miR-762	0.0329	0.1296	1.57	Down
	miR-92a	0.0015	0.0127	2.95	Up
	miR-92b	0.0463	0.1638	1.59	Down
	miR-93	0.0176	0.0822	1.55	Down
	miR-138	0.0480	0.1815	1.39	Up
Hind	miR-2137	0.0047	0.0363	1.99	Down
	miR-222	0.0359	0.1511	1.44	Up
	miR-271	0.0034	0.0283	2.74	Down
	miR-383	0.0010	0.0113	3.58	Up